Olanib 150 mg (Olaparib) is a PARP inhibitor used to treat ovarian, breast, pancreatic, and prostate cancers with BRCA mutations. It blocks DNA repair in cancer cells, causing cell death. Common side effects include nausea, fatigue, anemia, and low blood counts. Medical supervision is essential. https://oncologymedi.com/product/olanib-150-mg-olaparib/